Organon (Pharmaceuticals) Overview

  • Year Founded
  • 1923

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

  • Investments
  • 1

Organon (Pharmaceuticals) General Information

Description

Provider of drugs for the treatment of schizophrenia in adults. The company provides drugs for the treatment of schizophrenia in adults, and for the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults, as monotherapy or as adjunctive therapy with either lithium or valproate.

Contact Information

Website
www.saphris.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Oss
  • Netherlands
Primary Industry
Pharmaceuticals
Parent Company
Corporate Office
  • Oss
  • Netherlands

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Organon (Pharmaceuticals) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Organon (Pharmaceuticals)‘s full profile, request access.

Request a free trial

Organon (Pharmaceuticals) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Organon (Pharmaceuticals)‘s full profile, request access.

Request a free trial

Organon (Pharmaceuticals) Investments (1)

Organon (Pharmaceuticals)’s most recent deal was a Accelerator/Incubator with NAWAT Health for . The deal was made on 17-Oct-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
NAWAT Health 17-Oct-2024 Accelerator/Incubator Clinics/Outpatient Services
To view Organon (Pharmaceuticals)’s complete investments history, request access »

Organon (Pharmaceuticals) FAQs

  • When was Organon (Pharmaceuticals) founded?

    Organon (Pharmaceuticals) was founded in 1923.

  • Where is Organon (Pharmaceuticals) headquartered?

    Organon (Pharmaceuticals) is headquartered in Oss, Netherlands.

  • What industry is Organon (Pharmaceuticals) in?

    Organon (Pharmaceuticals)’s primary industry is Pharmaceuticals.

  • Is Organon (Pharmaceuticals) a private or public company?

    Organon (Pharmaceuticals) is a Private company.

  • What is Organon (Pharmaceuticals)’s current revenue?

    The current revenue for Organon (Pharmaceuticals) is .

  • Who are Organon (Pharmaceuticals)’s investors?

    Merck & Co. has invested in Organon (Pharmaceuticals).

  • When was Organon (Pharmaceuticals) acquired?

    Organon (Pharmaceuticals) was acquired on 02-Dec-2013.

  • Who acquired Organon (Pharmaceuticals)?

    Organon (Pharmaceuticals) was acquired by Forest Laboratories.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process